US0021202025 - Common Stock
aTyr Pharma to Participate in September Investor Conferences...
ATYR stock results show that aTyr Pharma beat analyst estimates for earnings per share the second quarter of 2024.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips aTyr Pharma (NASDAQ:ATYR) just reported results for the second quarter of 2024....
aTyr Pharma Announces Second Quarter 2024 Results and Provides Corporate Update ...
Study to explore role of the Company’s anti-NRP2 antibodies in glioblastoma multiforme (GBM), the most common type of primary brain cancer.
aTyr Pharma Completes Enrollment in Global Pivotal Phase 3 EFZO-FIT™ Study of Efzofitimod in Pulmonary Sarcoidosis...
ATYR stock results show that aTyr Pharma beat analyst estimates for earnings per share the second quarter of 2023.
Ticker symbol change to take effect on Wednesday, June 5, 2024
aTyr Pharma Announces Nasdaq Stock Ticker Symbol Change from “LIFE” to “ATYR” ...